Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anandagopal Srinivasan

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Plos One|December 13, 2018
Clinical outcomes of bortezomib-based therapy in myelomaFaouzi Djebbari, Anandagopal Srinivasan, Grant Vallance, et al.
BMJ Open|October 9, 2023
Secondary analysis of child hospital admission data for dental caries in London, UK: what the data tells us about oral health inequalitiesSarah Kaddour, Sebastian Slater, Robel Feleke, et al.
BMC Genomics|July 15, 2026
Distinct 5' and 3' coverage biases shape transcriptome interpretation in Nanopore direct RNA versus PCR-cDNA sequencingRebecca E Lane, Eleanor Calcutt, Anandagopal Srinivasan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 23, 2021
Daratumumab Monotherapy for Heavily Pre-treated and Refractory Myeloma: Results from a UK Multicentre Real World CohortNadjoua Maouche, Anandagopal Srinivasan, Heather Leary, et al.
Journal of Vascular Surgery|October 29, 2015
Premorbid function, comorbidity, and frailty predict outcomes after ruptured abdominal aortic aneurysm repairAnandagopal Srinivasan, Graeme K Ambler, Paul D Hayes, et al.
BJU International|April 29, 2016
Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a UK regional tertiary referral centreVincent J Gnanapragasam, David Thurtle, Anandagopal Srinivasan, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2017
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group studyEmeline Colomba, Gwénaël Le Teuff, Tim Eisen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Plos One|December 13, 2018
Clinical outcomes of bortezomib-based therapy in myelomaFaouzi Djebbari, Anandagopal Srinivasan, Grant Vallance, et al.
BMJ Open|October 9, 2023
Secondary analysis of child hospital admission data for dental caries in London, UK: what the data tells us about oral health inequalitiesSarah Kaddour, Sebastian Slater, Robel Feleke, et al.
BMC Genomics|July 15, 2026
Distinct 5' and 3' coverage biases shape transcriptome interpretation in Nanopore direct RNA versus PCR-cDNA sequencingRebecca E Lane, Eleanor Calcutt, Anandagopal Srinivasan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 23, 2021
Daratumumab Monotherapy for Heavily Pre-treated and Refractory Myeloma: Results from a UK Multicentre Real World CohortNadjoua Maouche, Anandagopal Srinivasan, Heather Leary, et al.
Journal of Vascular Surgery|October 29, 2015
Premorbid function, comorbidity, and frailty predict outcomes after ruptured abdominal aortic aneurysm repairAnandagopal Srinivasan, Graeme K Ambler, Paul D Hayes, et al.
BJU International|April 29, 2016
Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a UK regional tertiary referral centreVincent J Gnanapragasam, David Thurtle, Anandagopal Srinivasan, et al.
European Journal of Cancer (Oxford, England : 1990)|May 27, 2017
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group studyEmeline Colomba, Gwénaël Le Teuff, Tim Eisen, et al.
Pageof 1